We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Affordable Coagulation Analyzers Provide Broad Testing Range

By LabMedica International staff writers
Posted on 27 Jan 2015
The most common coagulation tests performed include PT, aPTT, and D Dimer. More...
While in some labs there is a need for PT, aPTT, D Dimer, and fibrinogen, others such as (component separation) blood banks routinely perform fibrinogen and Factor VIII. Another customer set, specializing in coagulopathy, tests for certain rare parameters. However, not all available systems are equipped to cater to these requirements. Also in need of immediate attention are: not having small reagent pack sizes for D Dimer and unavailability of timely service in remote areas.

Towards resolution of these critical issues and catering to diverse customer needs, Transasia Bio-Medicals Ltd (Mumbai, India), launched two advanced coagulation analyzers: ERBA ECL 105 – Single Channel and ERBA ECL 412 – Four Channel. Both analyzers use an innovative technology thereby providing highly accurate and precise results at affordable cost.

Both instruments include the following key highlights and features: LCD touchscreen graphical display; built-in incubator for cuvette; facility for reagent incubation through magnetic stirring of reagents (especially beneficial for mixing silica or latex based reagents as they require constant stirring to maintain suspension of particulate matter); inbuilt robust thermal printer; Connectivity through USB ports, ethernet ports, and RFID detection facility; storage of data and coagulation clotting curves is possible on an external drive. The test menu includes comprehensive range of tests from clotting to chromogenic (only onECL 412) and immunologic tests; light scattering principle is used for performing assays - Clotting (640 nm), Chromogenic (405 nm), and D Dimer (800 nm). The software is user-friendly, with minimal, simple logical inputs in programming tests, multi-standard calibration, plotting multilevel quality control (QC) points, and running tests. It also includes proven technology of coagulation curve in percentage light scatter for clot detection.

The ERBA ECL 105/412 performs comprehensive coagulation tests in semiautomated systems. The tests (such as fibrinogen, factors assays, Lupus anticoagulant, AT III (only on ECL 412), Protein C, Protein S, and D Dimer) are programmed and can be performed with minimum effort. The QC plotting has been programmed keeping in mind the accreditation requirement of laboratory. Multilevel QC for each test is possible, a feature still rare in many single- and four-channel analyzers.

Related Links:

Transasia Bio-Medicals



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.